Many organs are composed of complex tissue walls that are structurally organized to optimize organ function. In particular, the ventricular myocardial wall of the heart comprises an outer compact layer that concentrically encircles the ridge-like inner trabecular layer. Although disruption in the morphogenesis of this myocardial wall can lead to various forms of congenital heart disease 1 and non-compaction cardiomyopathies 2 , it remains unclear how embryonic cardiomyocytes assemble to form ventricular wall layers of appropriate spatial dimensions and myocardial mass. Here we use advanced genetic and imaging tools in zebrafish to reveal an interplay between myocardial Notch and Erbb2 signalling that directs the spatial allocation of myocardial cells to their proper morphological positions in the ventricular wall. Although previous studies have shown that endocardial Notch signalling non-cellautonomously promotes myocardial trabeculation through Erbb2 and bone morphogenetic protein (BMP) signalling 3 , we discover that distinct ventricular cardiomyocyte clusters exhibit myocardial Notch activity that cell-autonomously inhibits Erbb2 signalling and prevents cardiomyocyte sprouting and trabeculation. Myocardialspecific Notch inactivation leads to ventricles of reduced size and increased wall thickness because of excessive trabeculae, whereas widespread myocardial Notch activity results in ventricles of increased size with a single-cell-thick wall but no trabeculae. Notably, this myocardial Notch signalling is activated non-cellautonomously by neighbouring Erbb2-activated cardiomyocytes that sprout and form nascent trabeculae. Thus, these findings support an interactive cellular feedback process that guides the assembly of cardiomyocytes to morphologically create the ventricular myocardial wall and more broadly provide insight into the cellular dynamics of how diverse cell lineages organize to create form.
-o, arrows), whereas ventricular cardiomyocytes extending to form cardiac trabeculae fail to express Tp1:d2GFP ( Fig. 1a -h arrowheads). These Tp1:d2GFP + cardiomyocytes are frequently adjacent to sprouting Tp1:d2GFP − cardiomyocytes ( Fig. 1a -h) and form clusters of two or three cardiomyocytes across the surface of the ventricular myocardial wall ( Fig. 1m-t) , which quantitatively correlate with the number of emerging cardiac trabeculae (Extended Data Fig. 1p-r) . However, after the heart has established cardiac trabeculae, these Tp1:d2GFP + myocardial clusters progressively decrease and are no longer observed by 14 days post-fertilization (dpf), despite the presence of Tp1:d2GFP + AV and OFT endocardial cells ( Fig. 1i-l , o, p, s, t and Extended Data Fig. 1s, t) .
Using the Tg(Tp1:eGFP) Notch reporter line 12 , which expresses a more stable fluorescent protein than Tg(Tp1:d2GFP) (Extended Data Fig. 2a-h) , we observed that Tp1:eGFP + cardiomyocytes remain present in the ventricular outer wall until 30-45 dpf because of the eGFP perdurance, and then become the ventricular primordial layer by 60-90 dpf when the ventricular cortical layer of the adult zebrafish heart forms 4 (Extended Data Fig. 3a-n) . Unlike ventricular trabecular and cortical cardiomyocytes, these Tp1:eGFP + ventricular primordial cardiomyocytes fail to display organized sarcomeres by α-actinin immunostaining, are surrounded by extensive wheat germ agglutinin stained extracellular matrix and exhibit a thin cellular morphology as previously reported 4 (Extended Data Fig. 3o-t) . Overall, these data suggest that early myocardial Notch signalling may determine which ventricular cardiomyocytes remain in the embryonic ventricular outer wall to subsequently become the distinctive ventricular primordial layer of the adult zebrafish heart.
We next investigated the role of Notch signalling in the endocardium and myocardium during ventricular morphogenesis through selectively perturbing Notch signalling at specific cardiac developmental stages. Treating zebrafish embryos with DAPT, which effectively decreases Tp1:d2GFP Notch reporter expression and inhibits Notch signalling (Extended Data Fig. 2 ), from 20 to 48 hpf when Notch signalling is activated in the endocardium, reduces cardiac trabeculation (Extended Data Fig. 2q -s) as previously described 3 ; however, treating from 60 to 72 hpf, when Notch signalling is present in the ventricular myocardium, results in increased trabeculae formation ( Fig. 2a, b , i, j). Consistent with these results, BMP signalling, which is activated in ventricular trabeculae 3 , is also increased in similarly DAPT-treated zebrafish embryos from 60 to 72 hpf (Extended Data Fig. 4a-f ). Furthermore, heat-shocking Tg(hsp70l:dnMAML-GFP) 13 (abbreviated as hsp70l:dnM) embryos from 60 to 72 hpf, which induces dominant negative Mastermind-like (dnMAML) expression to block downstream Notch signalling, results in similar excessive trabeculation ( Fig. 2c, d , k, l).
To explore whether Notch signalling functions in a cardiomyocytespecific manner to directly guide myocardial cell fate position within the ventricle, we employed a myocardial-specific Cre (Extended Data Fig. 5a -d) strategy in combination with Tg(ubi:loxp-mKate2-STOPloxp-dnMAML-GFP) or Tg(hsp70l:loxp-mCherry-STOP-loxp-NICD-P2A-Emerald) 14 'switch lines' (abbreviated as ubi:RSdnM and hsp70l:RSN) to inhibit or activate Notch signalling in cardiomyocytes, respectively. As observed in DAPT-treated and heatshocked Tg(hsp70l:dnM) zebrafish from 60 to 72 hpf, Tg(myl7:Cre; ubi:RSdnM) zebrafish display excessive cardiac trabeculation due to inhibition of myocardial Notch signalling ( Fig. 2e , f, m, n). Conversely, 
heat-shocking Tg(myl7:Cre; hsp70l:RSN) zebrafish, which induces myocardial Notch-intracellular domain (NICD) expression, between 60 and 120 hpf leads to cardiac ventricles without significant trabeculae because of constitutively activated Notch signalling throughout the myocardium ( Fig. 2g , h, o, p). Moreover, constitutive myocardial Notch activation at later time points (80, 96, and 120 hpf to 7 dpf) prevents trabeculae from further sprouting and/or extending (Extended Data Fig. 6a -g); however, trabeculae continue to develop after the cessation of this myocardial Notch activity, but fail to recover to wild-type levels (Extended Data Fig. 6h , i).
In line with these findings, we discovered that Notch inhibition results in smaller ventricular areas ( Fig. 2a-f and Extended Data Fig. 5e ) and thicker ventricular myocardial walls ( Fig. 2a-f and Extended Data Fig. 5f ) due to increased cardiomyocytes within the trabecular layer (approximately two or three cells thick) ( Fig. 2i -n, Extended Data Fig. 5g ), whereas Notch activation gives rise to larger ventricular areas ( Fig. 2g , h, Extended Data Fig. 5e ) and thinner ventricular myocardial walls (Fig. 2g , h and Extended Data Fig. 5f ) that are about one cell thick with no apparent trabecular cardiomyocytes (Fig. 2o , p and Extended Data Fig. 5g ). Although these hearts do not exhibit a significant difference in overall cardiomyocyte numbers compared with control hearts (Extended Data Fig. 5h -p), we did discover that Notch inhibition promotes the redistribution of N-cadherin away from intercellular contacts whereas Notch activation prevents this reorganization (Extended Data Fig. 7 ), suggesting that myocardial Notch signalling may control ventricular size and wall thickness through regulating the allocation of cardiomyocytes between the ventricular wall layers via cell-cell contacts. To further investigate this possibility, we monitored the fate of individual genetically labelled cardiomyocytes using a myocardial specific Brainbow system Tg(myl7:CreER; priZm) 4 ( Fig. 2q-t ). After confirming that adjacent cardiomyocytes were consistently labelled with different colours at 60 hpf before trabeculation (Extended Data Fig. 8 ), we treated zebrafish embryos with DAPT or dimethylsulfoxide (DMSO) from 60 to 72 hpf. DAPT treatment leads to increased numbers of trabeculating clones and conversely decreased numbers of non-trabeculating clones compared with DMSO-treated hearts; however, the total number of ventricular cardiomyocyte clones is not significantly different ( Fig. 2r-t) , further supporting the idea that Notch signalling segregates individual cardiomyocyte clones between the ventricular outer wall and inner trabecular layers.
To examine whether Notch signalling acts cell-autonomously to control cardiomyocyte sprouting, we perturbed Notch signalling in individual cardiomyocytes during trabeculation by injecting hsp70l:loxp-mCherry-STOP-loxp-NICD-P2A-Emerald (hsp70l:RSN, Notch activating) or hsp70l:loxp-mCherry-STOP-loxp-dnSuH-P2A-Emerald 15 (hsp70l:RSdnS, dominant negative Suppressor of Hairless/Notch repressing) switch plasmids into Tg(myl7:Cerulean) 16 ; Tg(myl7:Cre) zebrafish embryos ( Fig. 2u ). Heat-shocking these injected fish from 60 to 72 hpf resulted in most Notch-activated NICD-P2A-Emerald + cardiomyocytes remaining in the ventricular outer myocardial wall ( Fig. 2w, z) , whereas Notch-inhibited dnSuH-P2A-Emerald + cardiomyocytes reside primarily in trabeculae ( Fig. 2y, z) . Heat-shocking injected control fish lacking Tg(myl7:Cre) generated mCherry + cardiomyocytes that were distributed equally between both myocardial layers ( Fig. 2v , x, z), altogether revealing a myocardial cell-autonomous role for Notch signalling.
Because Neuregulin/Erbb2 and BMP10 signalling can promote cardiac trabeculation 3,10,17 , we investigated whether myocardial Notch may cross-talk with these signalling pathways to regulate cardiomyocyte selection between the ventricular wall layers. Inhibiting Erbb2 signalling with AG1478 treatment 10 from 60 to 72 hpf prevents cardiac trabeculation and expression of Tp1:d2GFP in cardiomyocytes, although Tp1:d2GFP remains expressed in AV and OFT endocardial cells (Extended Data Fig. 9a, b ). Consistent with these findings, both erbb2 morpholino (MO) knockdown and erbb2 −/− mutant (erbb2 st50 ) Tg(Tp1:d2GFP) embryos, which exhibit similar trabecular defects 10,18 , also fail to display Notch reporter expression in the myocardium ( Fig. 3a, b, d) , supporting a requirement for Erbb2 signalling in the initiation of trabeculation and the activation of myocardial Notch signalling. Notably, neither DAPT treatment nor heat-shock induction of dnMAML between 60 and 72 hpf, which alone increases trabeculation ( Fig. 2) , could rescue the relative lack of cardiac trabeculae in zebrafish with loss of Erbb2 function (Fig. 3c , e and Extended Data Fig. 9b-e ). In contrast to the Erbb2 loss of function findings, embryos treated with Dorsomorphin 19 from 60 to 72 hpf to inhibit BMP signalling still form cardiac trabeculae and express Tp1:d2GFP in the outer myocardial wall (Extended Data Fig. 4m -p) despite the abrogation of the BMP-reporter signal (BRE:d2GFP) in the trabecular layer (Extended Data Fig. 4j -l). However, by 7 dpf, these hearts display aberrant and stunted cardiac trabeculae compared with DMSO-treated fish (Extended Data Fig. 4q-s) , corroborating a requirement for BMP signalling in the maintenance but not the initiation of cardiac trabeculation 20 .
To explore whether Notch activation negatively regulates Erbb2 signalling to prevent trabeculae formation, we examined erbb2 expression in 72 hpf Tp1:d2GFP hearts and discovered that erbb2 is expressed in many ventricular cardiomyocytes but diminished in Tp1:d2GFP + cardiomyocytes (Extended Data Fig. 9f -j). In support of these findings, constitutive myocardial Notch activation by heat-shocking Tg(myl7:Cre; hsp70l:RSN) fish between 60 and 120 hpf results in the dramatic reduction of erbb2 myocardial expression (Extended Data Fig. 9k , l, o, p). In contrast, Notch-inhibited hearts treated with DAPT from 60 to 72 hpf exhibit increased erbb2 myocardial expression (Extended Data Fig. 9m , n, q, r). Thus, myocardial Notch signalling may block Neuregulin/Erbb2 signalling by downregulating erbb2 expression to inhibit cardiomyocyte sprouting.
Since Notch signalling has been shown to mediate cell fate position through lateral inhibition mechanisms 6, 7, 21, 22 , we investigated whether Erbb2 signalling non-cell-autonomously activates myocardial Notch signalling in neighbouring cardiomyocytes. Thus, we created mosaic embryos by transplanting Tg(myl7:Cerulean) wild-type donor blastomeres into erbb2 or control MO injected Tg(Tp1:d2GFP); Tg(myl7:H2A-mCherry) 23 host embryos and assessed the ability of wild-type donor cells to contribute to the ventricular wall layers and activate myocardial Notch signalling. As previously reported 10 , a greater percentage of donor-derived wild-type cardiomyocytes is present in the trabeculae of erbb2 knockdown embryos compared with control embryos (compare Fig. 3i with Fig. 3g ; Extended Data Fig. 10a ). Although non-transplanted erbb2 knockdown hearts fail to exhibit myocardial Notch activity ( Fig. 3f, h) , transplanted erbb2 knockdown host hearts containing wild-type donor myocardial cells (myl7:Cerulean + ) can activate myocardial Tp1:d2GFP expression ( Fig. 3i and Extended Data Fig. 10b ). Upon closer inspection, these host erbb2 knockdown Tp1:d2GFP + cardiomyocytes (Fig. 3i , arrows) appear adjacent to donor wild-type myl7:Cerulean + cardiomyocytes ( Fig. 3i , arrowheads, and Extended Data Fig. 10c ), supporting a role for Erbb2-responsive cardiomyocytes in activating Notch signalling in neighbouring cardiomyocytes.
On the basis of these results, we searched for potential Notch ligands mediating the activation of Notch signalling in neighbouring cardiomyocytes and discovered that jag2b is expressed in select ventricular cardiomyocytes at 72 hpf when myocardial Notch signalling is activated ( Fig. 4a, b ). This ventricular myocardial jag2b expression is reduced in erbb2 −/− mutant hearts ( Fig. 4c, d ), suggesting that Erbb2 signalling may activate Notch signalling in neighbouring cardiomyocytes through jag2b. In support of this possibility, we discovered that jag2b −/− mutant hearts exhibit not only increased trabeculation as observed in Notchinhibited hearts but also reduced Tp1:d2GFP Notch reporter activity in the ventricular myocardium but not in the AV or OFT endocardium ( Fig. 4e-h ). Together these data support a model in which myocardial Erbb2 signalling non-cell-autonomously activates Notch signalling in neighbouring ventricular outer-wall cardiomyocytes through Jag2b, which in turn leads to the reduction of erbb2 expression, subsequent inhibition of Erbb2 signalling, and suppression of cardiomyocyte sprouting ( Fig. 4i-k) .
Overall, these findings reveal a molecular mechanism whereby Notch and Erbb2 signalling coordinates social cellular interactions between cardiomyocytes that determine their morphological fate within the ventricular wall. Although previous studies have suggested that Notch signalling may be activated in the myocardium [24] [25] [26] [27] , our zebrafish studies illuminate the precise role of myocardial Notch activity in forming the ventricular wall. Similar to the receptor tyrosine kinase (RTK)-Notch lateral inhibition signalling mechanisms that regulate epithelial tip and stalk cell formation during branching morphogenesis 6,7 , myocardial Notch acts in concert with the RTK Erbb2 to segregate embryonic cardiomyocytes into two functionally distinct classes of cells: (1) sprouting cardiomyocytes that respond to Neuregulin via Erbb2 and (2) non-sprouting Notch-activated cardiomyocytes, in which Notch signalling inhibits erbb2 expression. These roles appear not to be pre-specified, but rather are determined by social interactions between cardiomyocytes. Furthermore, recent studies have reported human Notch genetic variants linked to a wide spectrum of congenital heart diseases including non-compaction cardiomyopathies 28, 29 , which exhibit similar severe ventricular wall defects to those observed in our Notch studies. More broadly, our studies support a conserved role for intercellular cross-talk between RTKs and Notch signalling for allocating cells within organ substructures and might be particularly relevant in developing strategies for human pluripotent stem-cell tissue-specific developmental and disease modelling or regenerative therapies.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. To generate the Tg(myl7:Cre) sd38 transgenic line, a 900-base-pair fragment of the myl7 promoter 35 was cloned upstream of the Cre recombinase gene into a multi-cloning site flanked by I-SceI sites in the pBluescript-SK vector. Standard I-SceI meganuclease transgenesis 36 was used to create transgenic founders which were screened for myocardial Cre recombinase activity by crossing to the Tg(β-act2:RSG) s928 line. Three independent founders were identified, all with similar levels of Cre recombinase activity and matching the expression of Tg(myl7:Cerulean) co19 (Extended Data Fig. 5a-d) . A single representative founder was propagated further.
To generate the Tg(ubi:loxp-mKate2-STOP-loxp-dnMAML-GFP) fb16 strain, abbreviated as Tg(ubi:RSdnM), gateway cloning technology (Life Technologies) was used to conduct an LR recombination reaction with the pENTR5′_ubi 37 , pMEloxp-mKate2-STOP-loxp, p3E-dnMAML-GFP entry vectors and the pDESTol2pA2 destination vector 38 . The pME-loxp-mKate2-STOP-loxp entry vector was created by replacing the AmCyan complementary DNA in the pME-loxp-AmCyan-STOP-loxp 39 vector with a complementary DNA encoding mKate2 (Evrogen) using In-Fusion HD cloning (Clontech Laboratories). The p3E-dnMAML-GFP entry vector was generated by conducting a BP recombination reaction between a PCR product encoding a fusion protein between dnMAML and GFP amplified from pME-dnMAML-GFP 13 and the Gateway Donor Vector pDONRP2R-P3. Altogether the ubi:loxp-mKate2-STOP-loxp-dnMAML-GFP construct was co-injected with Tol2 transposase mRNA 38 into one-cell stage embryos to generate independent founders which were screened for mKate2 and then GFP upon Cre-mediated recombination. Founders with both mKate2 and GFP were propagated further. Embryonic immunofluorescence and live imaging studies. Wholemount immunofluorescence studies were performed as previously described 40 , with the following modifications. After initial fixation, any pre-existing fluorescence was quenched by incubating embryos in 2 M HCl at 37 °C for 30 min and washing with double-distilled H 2 O and phosphate buffer saline with 0.1% Tween-20 (PBST). The antibodies used were anti-Mef2/C-21 (rabbit, Santa Cruz Biotechnology, 1:100), anti-MHC/MF20 (mouse, Developmental Studies Hybridoma Bank, 1:100) or anti-N-cadherin (rabbit, GeneTex, 1:100) followed by anti-rabbit IgG-Alexa 488 (goat, Life Technologies 1:200).
For embryonic studies of Notch activity, embryos containing the Notch reporters Tg(Tp1:d2GFP) mw43 or Tg(Tp1:eGFP) um14 in combination with myocardialexpressed transgenes such as Tg(myl7:mCherry) sd7 or endothelial expressed transgenes such as Tg(kdrl:ras-mCherry) S896 were imaged live 40 . The Tp1 promoter used in these Notch reporter transgenics consists of 12 RPBJ-binding sites and reports Notch activity throughout the embryo as previously published 8, 12 . These embryos were embedded in 1% low melting agarose (Lonza) in a coverslip bottom culture dish (MatTek) and cardiac contraction was arrested using Tricaine-S (Sigma MS-222) just before imaging.
To count the number of Tp1:d2GFP + clusters in each heart, we used threedimensional reconstructions (Nikon NIS Elements software) from confocal stacks of Tg(Tp1:d2GFP; myl7:mCherry) embryos (5-16 hearts per stage). To count the number of cardiomyocytes per Tp1:d2GFP + cluster, Tg(Tp1:d2GFP; myl7:H2A-mCherry) embryos were used. Only cells expressing both H2A-mCherry and d2GFP were counted. We analysed five to ten hearts per stage to obtain the average number of cardiomyocytes in each Tp1:d2GFP cluster at each specified stage. Statistical analysis is described in the 'Image processing and statistical analysis' section below.
To assess the correlation between nascent trabeculae and Tp1:d2GFP + clusters at 72 hpf, trabeculae were identified in consecutive slices from a Z-stack and pseudo-coloured with magenta. A three-dimensional reconstruction was then used to generate the full view of the ventricle, where the number of nascent trabeculae and Tp1:d2GFP + clusters could be counted in each heart. These data are represented in a scatter plot (Extended Data Fig. 1r ) and used to overlay a linear regression line. Adult immunofluorescence and imaging studies. Immunofluorescence studies were conducted on cryosections of adult zebrafish hearts. These hearts were cryoprotected, mounted, sectioned, and stained as performed previously 40 . The following primary antibodies were used: anti-MHC/MF20 (mouse, Developmental Studies Hybridoma Bank, 1:100); anti-α-actinin (mouse, Diagnostic BioSystems, 1:100); anti-Raldh2 (rabbit, Abmart, 1:100); and anti-GFP (chicken, Aves Labs, 1:200). The following secondary antibodies were used: anti-mouse IgG-Alexa 405 (goat, Life technologies, 1:200), anti-mouse IgG-Alexa 594 (goat, Life Technologies, 1:200), anti-rabbit IgG-Alexa 568 (goat, Life Technologies, 1:200) and anti-chicken IgG-Alexa 488 (goat, Life Technologies, 1:200). Alexa Fluor 594-conjugated wheat germ agglutinin (Life Technologies, 50 μg ml −1 ) was used to stain the extracellular matrix. DAPI (1 μg ml −1 ) staining was used to identify nuclei. Notably, we discovered that eGFP from the Tg(Tp1:eGFP) um14 transgene perdured for a longer period in the ventricular outer myocardial wall (Extended Data Fig. 3 ) than d2GFP from the Tg(Tp1:d2GFP) mw43 transgene (Extended Data Fig. 1) . Notch signalling studies. Notch inhibition studies were performed using DAPT (a chemical inhibitor of γ-secretase) or dnMAML mis-expression (dominant negative mastermind-like 1). DAPT: zebrafish embryos were incubated in 100 μM DAPT (Sigma) or 0.1% DMSO alone (control) at specified developmental stages and time intervals and then quickly washed (two or three times) with egg water (60 μg ml −1 Instant Ocean sea salts) for further analysis. The ability of 100 μM DAPT treatment to inhibit Notch signalling was validated by examining Tp1:d2GFP expression after DAPT treatment (Extended Data Fig. 2i-p) . dnMAML: The Tg(hsp70l:dnM) was used to globally express dnMAML at specified time points. Heat-shock induction was conducted by placing Tg(hsp70l:dnM) or wild-type siblings into a 37 °C incubator for 30 min, followed by 3 min in a 42 °C water bath. Embryos were heat-shocked twice every 24 h to maintain the induction of dnMAML-GFP throughout the embryo. This protocol was highly efficient at inducing dnMAML-GFP expression and produced minimal lethality. To inhibit Notch signalling in cardiomyocytes only, the Tg(ubi:loxp-mKate2-STOP-loxp-dnMAML-GFP) line was crossed with the Tg(myl7:Cre) line to produce embryos which express dnMAML-GFP only in the myocardium. Induction of dnMAML-GFP was verified by examining GFP fluorescence 5-6 h after heat shock or Cre-mediated recombination 13 .
Notch activation was performed by expressing NICD. Heat shocking embryos containing both Tg(hsp70l:loxp-mCherry-STOP-loxp-NICD-P2A-Emerald) 14 and Tg(myl7:Cre) transgenes produced NICD-P2A-Emerald only in the myocardium. Heat shock was performed as described above.
Ventricular wall thickness was measured to quantify the effect of perturbing Notch signalling and was determined by drawing five representative lines perpendicular to the ventricular wall in a representative confocal slice. Thickness was measured as the distance along the line between the lateral and medial edge of the myocardial wall. All hearts were imaged in the same orientation and comparable confocal slices were chosen for analysis. Six hearts were measured for each condition.
To determine the effect of altering Notch signalling on cardiomyocyte cell numbers within the ventricular outer wall and trabecular layers, ventricular cardiomyocyte nuclei were counted from hearts exposed to specified experimental conditions using three-dimensional reconstructions of confocal slices from embryos with myl7:H2A-mCherry or from embryos stained with the Mef2 antibody. Mef2 immunostaining was used in embryos containing transgenes with fluorophores that overlapped with H2A-mCherry, such as ubi:RSdnM or hsp70l:RSN. For these analyses, the cells within the trabeculae could be separated from the ventricular outer wall using the post-image processing procedure described in the 'Image processing and statistical analysis' section below. Using this procedure, we calculated the number of cardiomyocyte nuclei in the total ventricle and the number of cardiomyocyte nuclei within the trabeculae. The number of cardiomyocyte nuclei in the ventricular outer wall was calculated by subtracting the number of cardiomyocytes in the trabeculae from the total.
Trabeculae area was measured from a confocal slice of a ventricle containing a cytoplasmic fluorophore such as myl7:mCherry or ubi:RSdnM or hsp70l:RSN. Confocal slices at the level of the AV canal were analysed. Non-trabecular tissue in these images was masked manually and then the total number of fluorescent pixels was measured using the IDL program (Research Systems). All images were taken at the same dimensions. Ventricle area was determined by measuring the total pixels outlined in the ventricle region using ImageJ software. Clonal analysis. Cardiomyocyte clones were genetically labelled by combining the myl7:CreER and priZm (β-act2:Brainbow1.0L) 4 transgenes and then treating with 4-hydroxytamoxifen (4-HT, Sigma). Specifically, zebrafish embryos with these transgenes were treated at 48 hpf, when the zebrafish heart consists of a single cardiomyocyte thick wall and is looped but has not initiated cardiac trabeculation, Letter reSeArCH with 10 μM 4-HT or 0.1% ethanol (control) for 6 h at 28 °C and then washed with fresh egg water several times. The dose and length of incubation of 4-HT was titrated to create small distinct clones (one or two cells) before trabeculation (Extended Data Fig. 8 ). The total numbers of cardiomyocyte clones were counted from three-dimensional reconstructions of confocal slices from hearts containing myl7:CreER and priZm transgenes. Visualization and counting of clones solely within the trabeculae were analysed using the post-imaging processing procedure described in the 'Image processing and statistical analysis' section below. Mosaic analysis by DNA injection. To create the hsp70l:loxp-mCherry-STOPloxp-dnSuH-P2A-Emerald plasmid (abbreviated as hsp70l:RSdnS), the dominant negative Suppressor of Hairless 15 (dnSuH) DNA construct was PCR amplified with flanking AscI and SacII restriction sites. After sequence verification, this dnSuH product was subcloned into the hsp70l:loxp-mCherry-STOP-loxp-NICD-P2A-Emerald 14 construct (hsp70l:RSN), replacing the NICD sequence and generating the hsp70l:loxp-mCherry-STOP-loxp-dnSuH-P2A-Emerald (hsp70l:RSdnS) construct for subsequent injection studies (see below). To generate cardiomyocyte clones with constitutively activated or inhibited Notch signalling, the I-SceI enzyme was co-injected with either the hsp70l:RSN plasmid (25 pg) or the hsp70l:RSdnS (25 pg) plasmid into one-cell stage embryos containing Tg(myl7:Cre; myl7:Cerulean) or only Tg(myl7:Cerulean). Embryos were then heat-shocked (as described above) at 60 hpf and imaged at 72 hpf. Cardiomyocytes containing either plasmid were detected by the co-expression of mCherry or Emerald and Cerulean. The location of Notch-altered Emerald + cardiomyocytes clones in either the ventricular outer wall or the trabeculae was determined using the method described within the 'Image processing and statistical analysis' section below. Erbb2 and BMP loss of function studies. The activity of Erbb2, a tyrosine kinase receptor, was inhibited using (1) homozygous erbb2 st50 mutants 18 , (2) a splice morpholino targeting erbb2 (erbb2 MO) 10 , or (3) the tyrosine kinase inhibitor AG1478 (Calbiochem). (1) The erbb2 st50 homozygous mutant embryos were identified by the previously characterized aberrant cardiac morphology 18 . (2) The erbb2 MO was previously characterized and shown to be specific 10 . We injected 570 pg of the erbb2 morpholino (erbb2 MO) or a mismatched control morpholino (control MO) into one-cell stage embryos as previously described 10 . (3) AG1478 (5 μM; Calbiochem) or 0.1% DMSO (control) was added to embryos as previously described 10 . After incubation, embryos were washed extensively with egg water for further analysis. The erbb2 MO injections or AG1478 incubations phenocopied the erbb2 st50 mutant phenotype ( Fig. 3 and Extended Data Fig. 9 ).
To investigate the relationship between Notch signalling and erbb2, erbb2 MO embryos or erbb2 st50 mutant embryos were incubated with 100 μM DAPT (Sigma) or 0.1% DMSO at 60 hpf as described above. In complementary experiments, Tg(hsp70l: dnMAML-GFP) embryos were injected with the erbb2 MO and heatshocked at 60 hpf as described above.
To inhibit BMP signalling, embryos were incubated with 30 μM of Dorsomorphin (Sigma) as previously described 41 . The efficacy of Dorsomorphin was verified by examining its effect on the BMP reporter, Tg(BRE:d2GFP). Cell transplantation studies. Blastomere transplantation was performed at the mid-blastula stage as previously described 23 . Ten to twenty cells were removed from mid-blastula donor Tg(myl7:Cerulean) embryos and placed along the margin of either control MO or erbb2 MO host Tg(Tp1:d2GFP; myl7:H2A-mCherry) embryos. Transplanted embryos in which donor cells contributed to the heart were imaged at 72 hpf. Image analysis of whether donor cells contributed to the ventricular outer wall or trabeculae and their location relative to Tp1:d2GFP + cells was assessed in single confocal slices or in three-dimensional reconstructions using the post-imaging procedures described within the 'Image processing and statistical analysis' section below. In situ hybridization expression analyses. Fluorescent in situ hybridization studies of erbb2 and jag2b were performed as described in the ViewRNA in situ hybridization 1-Plex kit protocol (Affymetrix Panomics) with the following modifications. After the initial fixation, existing fluorescence was quenched as described for embryonic immunofluorescence above. Embryos were then subjected to protease digestion (protease QF, 1:100) at 40 °C for 30 min, followed by PBST washes and re-fixation in 4% PFA at 25 °C for 20 min. After additional PBST washes, hybridization was performed with erbb2 probes (Affymetrix Panomics VF1-16871, 1:50 dilution) or jag2b probes (Affymetrix Panomics VF1-18462, 1:50 dilution) at 40 °C overnight. Hybridized embryos were then washed in PBST and stepped through pre-labelling solutions. Embryos were then incubated with label probe-AP solution (1:1,000) for 30 min at 40 °C, washed again, transferred to a AP-enhancer solution and then transferred to fast red solution (one fast red substrate tablet in 5 ml naphthol buffer) for 30 min at 40 °C. After PBST washes, embryos were incubated in anti-MHC/MF20 antibody (mouse, Developmental Studies Hybridoma Bank, 1:100) or anti-GFP antibody (chicken, Aves Labs, 1:200) overnight at 4 °C. After PBST washes, embryos were incubated in anti-mouse IgG-Alexa 488 (goat, Life Technologies, 1:200) or anti-chicken IgG-Alexa 488 antibodies (goat, Life Technologies, 1:200) for 1 h at 25 °C. Finally, embryos were washed and mounted for imaging. PBST washing consisted of three washes for 15 min each at 25 °C. For gfp mRNA expression analysis, wholemount in situ hybridization studies were performed as previously described 40 . Image processing and statistical analysis. All images were obtained using a Nikon C2 confocal microscope and processed using Nikon NIS Elements software and ImageJ as previously described 40 . Scale bars for all images represent 25 μm. Measurements comparing the ventricular outer wall with the trabeculae were performed with post-image processing of confocal slices. Visualization of all cardiomyocytes and clones within the ventricle (comprising both the ventricular outer wall and the trabeculae) were made using three-dimensional reconstructions (Nikon NIS Elements) of confocal slices. However, to visualize only the trabeculae, cardiomyocytes within the ventricular outer wall in individual confocal slices were identified by their outer location and orientation and then masked manually. Three-dimensional reconstructions with these masked confocal slices then allowed the visualization and measurement of trabeculae alone. Measurements for the ventricular outer wall alone were calculated by subtracting the measurements of the trabeculae from the total ventricular cardiomyocytes. No statistical methods were used to predetermine sample size. Animals were assigned to experimental groups using simple randomization, without investigator blinding. Unpaired two-tailed Student's t-tests or Fisher's exact tests were used to determine statistical significance. P < 0.05 was considered to be statistically significant, as indicated by an asterisk. Error bars, s.e.m.
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Extended Data Figure 1 | Notch signalling is dynamically activated in the endocardium and myocardium during heart development. a-f, Confocal slices of Tg(Tp1:d2GFP; myl7:mCherry) hearts reveal that Notch signalling is in the ventricular endocardium (yellow arrows) but not in the myocardium at 24 hpf (n = 11) and 36 hpf (n = 8), but (g-i) becomes restricted to the AV and OFT endocardium by 48 hpf (n = 12). j-o, Tg(Tp1:d2GFP; kdrl:ras-mCherry) confocal imaging confirms that Tp1:d2GFP is expressed in the ventricular endocardium at (j-l) 24 hpf (n = 8) but becomes localized to the AV or OFT endocardium as well as non-endocardial cells in the outer ventricular myocardial wall (white arrows) by (m-o) 96 hpf (n = 10). p, q, Three-dimensional confocal reconstructions of the (p) exterior and (q) interior regions of 72 hpf Tg(Tp1:d2GFP; myl7:mCherry) hearts reveal that Notch-activated Tp1:d2GFP + cells are present in cardiomyocyte clusters (green, numbers in parentheses) and excluded from nascent cardiac trabeculae (pseudocolour magenta, numbers). r, Graph shows that the number of cardiac trabeculae (x axis) and Tp1:d2GFP + cardiomyocyte clusters (y axis) are similar within the ventricle (n = 30) at 72 hpf. Size of dots indicates the number of embryos with a particular number of trabeculae and Tp1:d2GFP + clusters. Line represents a linear regression fitted to the data. s, t, Myocardial anti-MHC/MF20 immunostaining of Tg(Tp1:d2GFP) hearts reveals a loss of myocardial Tp1:d2GFP Notch reporter signal at 30 and 90 dpf hearts (n = 5 hearts per stage). White arrows, likely Tp1:d2GFP + cardiomyocytes; yellow arrows, Tp1:d2GFP + endocardial cells; white and yellow asterisks, AV and OFT. Dashed line in s outlines ventricle. V, ventricle; A, atrium. Scale bar, 25 μm.
Extended Data Figure 5 | Altering myocardial Notch signalling affects ventricular size and wall thickness but not total number of ventricular cardiomyocytes. a-d, The Tg(myl7:Cre) transgenic line used to specifically perturb Notch signalling in the myocardium was validated by confirming that Cre expression is restricted to the myocardium. Activity of myl7:Cre, as visualized by (c) GFP expression from the switch line, β-act2:RSG, exclusively overlaps with (b, d) myl7:Cerulean expression at 120 hpf (n = 10 embryos). Quantitative analyses of (e) ventricular size and (f) wall thickness performed on confocal images from Fig. 2a -h reveal that myocardial Notch signalling restricts ventricular size while promoting ventricular wall thickness. e, Ventricular size measurements were normalized to respective controls for each condition. f, Individual measurements (dots) of myocardial thickness were taken across the outer curvature of the ventricle (n = 30 measurements, 6 measurements were taken per embryo, 5 embryos per condition). Dashed line represents the ventricular wall thickness that distinguishes trabeculated myocardial thickness from ventricular outer wall myocardial thickness in control hearts. Crosses denote mean and s.e.m. g-p, Quantitative analysis of (g) trabecular cardiomyocytes and (p) total ventricular cardiomyocytes was calculated by counting myocardial nuclei labelled with myl7: H2A-mCherry or anti-Mef2 immunostaining using embryos from Fig. 2i -p for g, or from three-dimensional reconstructions in h-o for p. In g, the number of trabecular/total ventricular cardiomyocytes was used to calculate the percentage of trabecular cardiomyocytes for each condition. In p, total ventricular cardiomyocytes were normalized to respective controls for each condition. n, Number of embryos analysed per condition. Mean ± s.e.m. *P < 0.05 by Student's t-test. NS, not significant. Scale bar, 25 μm.
Extended Data Figure 10 | Transplanted wild-type cardiomyocytes non-cell-autonomously activate Notch signalling in erbb2 morphant host cardiomyocytes. a, On the basis of mosaic embryo studies from Fig. 3f -i, wild-type donor cardiomyocytes contribute equally to the outer ventricular wall (14/26 clones) or the trabeculae (12/26 clones) when transplanted into control MO host embryos (n = 12 embryos). However, when wild-type donor cells are transplanted into erbb2 MO host embryos (n = 10 embryos), they contribute more to the trabecular layer (19/23 clones) than to the ventricular outer wall (4/23 clones, P < 0.05 by Fisher's exact test). b, On the basis of mosaic embryo studies from Fig. 3f -i, transplanting wild-type donor cells increases the number of erbb2 MO host cardiomyocytes expressing Tp1:d2GFP (n = 10 embryos) compared with non-transplanted erbb2 MO embryos (n = 16 embryos), but had no effect on the number of control MO host cells expressing Tp1:d2GFP (n = 12 embryos) compared with non-transplanted controls (n = 11 embryos). c, Quantitative data for Fig. 3f -i reveal that transplanted wildtype donor cardiomyocytes are primarily adjacent to host Tp1:d2GFP + cardiomyocytes in erbb2 MO hearts (n = 10 embryos). Mean ± s.e.m. *P < 0.05 by Student's t-test. NS, not significant.
